FDA details plan to end emergency use authorizations for devices

With the COVID-19 public health emergency set to expire on May 11, medical technology companies that brought devices to market under special pandemic rules will need to prepare transition plans soon, the Food and Drug Administration said in final guidance issued on March 24.